SVP, CFO of BioMarin Pharmaceutical Inc. (BMRN, Financial) Jeffrey H Cooper sells 2,500 shares of BMRN on 11/01/2011 at an average price of $33.26 a share.
Biomarin Pharmaceutical Inc. has a market cap of $3.61 billion; its shares were traded at around $32.28 with and P/S ratio of 9.5.
For the complete insider trading history of BMRN, click here.
Biomarin Pharmaceutical Inc. has a market cap of $3.61 billion; its shares were traded at around $32.28 with and P/S ratio of 9.5.
CEO Recent Trades:
- CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 09/28/2011 at the average price of 32. Jean Jacques Bienaime owns at least 126,093 shares after this. The price of the stock has increased by 0.88% since.
- CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 08/30/2011 at the average price of 29.01. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 11.27% since.
- CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 08/19/2011 at the average price of 26.75. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 20.67% since.
- CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 08/12/2011 at the average price of 27.1. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 19.11% since.
- CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 08/02/2011 at the average price of 30.27. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 6.64% since.
CFO Recent Trades:
- SVP, CFO Jeffrey H Cooper sold 18,379 shares of BMRN stock on 10/10/2011 at the average price of 34. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has decreased by 5.06% since.
- SVP, CFO Jeffrey H Cooper sold 18,379 shares of BMRN stock on 09/28/2011 at the average price of 32. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 0.88% since.
- SVP, CFO Jeffrey H Cooper sold 2,500 shares of BMRN stock on 09/01/2011 at the average price of 29.41. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 9.76% since.
- SVP, CFO Jeffrey H Cooper sold 18,036 shares of BMRN stock on 08/02/2011 at the average price of 30.47. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 5.94% since.
- SVP, CFO Jeffrey H Cooper sold 18,378 shares of BMRN stock on 07/14/2011 at the average price of 30. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 7.6% since.
Directors and Officers Recent Trades:
- SVP, General Counsel George Eric Davis sold 260 shares of BMRN stock on 11/01/2011 at the average price of 33.23. George Eric Davis owns at least 39,651 shares after this. The price of the stock has decreased by 2.86% since.
- EVP, Chief Business Officer Steve Aselage sold 16,875 shares of BMRN stock on 10/28/2011 at the average price of 35. Steve Aselage owns at least 46,478 shares after this. The price of the stock has decreased by 7.77% since.
- VP, Human Resources Mark Wood sold 1,853 shares of BMRN stock on 10/24/2011 at the average price of 33.32. Mark Wood owns at least 20,634 shares after this. The price of the stock has decreased by 3.12% since.
- EVP, Chief Medical Officer Henry J Fuchs sold 2,500 shares of BMRN stock on 10/03/2011 at the average price of 31. Henry J Fuchs owns at least 36,455 shares after this. The price of the stock has increased by 4.13% since.
- VP, Human Resources Mark Wood sold 1,854 shares of BMRN stock on 09/22/2011 at the average price of 29.92. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 7.89% since.
For the complete insider trading history of BMRN, click here.
